Skip to main content
Erschienen in: Rheumatology International 11/2012

01.11.2012 | Original Article

Evaluation of the mean platelet volume in children with familial Mediterranean fever

verfasst von: Seçil Arıca, Cahit Özer, Vefik Arıca, Ali Karakuş, Tanju Çelik, Ramazan Güneşaçar

Erschienen in: Rheumatology International | Ausgabe 11/2012

Einloggen, um Zugang zu erhalten

Abstract

To evaluate the Mean Platelet Volume (MPV) levels in children diagnosed with familial Mediterranean fever (FMF), during attack and attack-free periods. The records of a total of 117 children with FMF, diagnosed using the Tel-Hashomer criteria, have been scanned. The study consisted of 53 patients during an attack (group 1), 64 patients in attack-free period (group 2), and 57 healthy controls (group 3). Erythrocyte sedimentation rate, C-reactive protein, white blood cell count, platelet count, and MPV levels were retrospectively recorded. The MPV and platelet values in FMF patients during attack (group 1) and FMF patients during attack-free periods (group 2) have been found to be significantly higher than those of the health control group (group 3). Positive correlation has been found between the MPV and platelet values in Group 1 and the disease’s severity score (r = 0.224, and r = 0.268, respectively). Positive correlation (r = 0.528, and r = 0.485, respectively) has been also identified between MPV and blood platelet count in patients in Group 1 and 2. No correlation was found between the Colchicine treatment period and MPV (r = −0.005). The MPV values in the complete group of FMF diagnosed children have been found to be much higher compared to those in healthy children. As a consequence, we consider the MPV value as a useful marker that demonstrates the risk of early stage atherosclerosis in children with FMF.
Literatur
1.
Zurück zum Zitat El-Shanti H, Majeed HA, El-Khateeb M (2006) Familial mediterranean fever in Arabs. Lancet 367(9515):1016–1024PubMedCrossRef El-Shanti H, Majeed HA, El-Khateeb M (2006) Familial mediterranean fever in Arabs. Lancet 367(9515):1016–1024PubMedCrossRef
2.
Zurück zum Zitat Cassidy JT, Petty RE (2005) Periodic fever syndromes in children. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 657–690 Cassidy JT, Petty RE (2005) Periodic fever syndromes in children. In: Cassidy JT, Petty RE (eds) Textbook of pediatric rheumatology, 5th edn. Elsevier, Philadelphia, pp 657–690
3.
Zurück zum Zitat Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R (2001) Familial mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 9:3–7CrossRef Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R (2001) Familial mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 9:3–7CrossRef
4.
Zurück zum Zitat Kone-Paut I, Dubuc M, Sportouch J et al (2000) Phenotype-genotype correlation in 91 patients with familial mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatol 39:1275–1279CrossRef Kone-Paut I, Dubuc M, Sportouch J et al (2000) Phenotype-genotype correlation in 91 patients with familial mediterranean fever reveals a high frequency of cutaneomucous features. Rheumatol 39:1275–1279CrossRef
5.
Zurück zum Zitat Daniels M, Shohat T, Brenner-Ullman A, Shohat VI (1995) Familial mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am J Med Genet 55:311–314PubMedCrossRef Daniels M, Shohat T, Brenner-Ullman A, Shohat VI (1995) Familial mediterranean fever: high gene frequency among the non-Ashkenazic and Ashkenazic Jewish populations in Israel. Am J Med Genet 55:311–314PubMedCrossRef
6.
Zurück zum Zitat Bagci S, Toy B, Tuzun A et al (2004) Continuity of cytokine activation in patients with familial mediterranean fever. Clin Rheumatol 23:333–337PubMedCrossRef Bagci S, Toy B, Tuzun A et al (2004) Continuity of cytokine activation in patients with familial mediterranean fever. Clin Rheumatol 23:333–337PubMedCrossRef
7.
Zurück zum Zitat Zemer D, Pras M, Sohar E et al (1974) Colchicine in the prevention and treatment of the amyloidosis of familial mediterranean fever. New Eng J Med 314:1001–1005CrossRef Zemer D, Pras M, Sohar E et al (1974) Colchicine in the prevention and treatment of the amyloidosis of familial mediterranean fever. New Eng J Med 314:1001–1005CrossRef
8.
Zurück zum Zitat Caliskan M, Gullu H, Yilmaz S et al (2007) Impaired coronary microvascular function in familial mediterranean fever. Atherosclerosis 195:161–167CrossRef Caliskan M, Gullu H, Yilmaz S et al (2007) Impaired coronary microvascular function in familial mediterranean fever. Atherosclerosis 195:161–167CrossRef
9.
Zurück zum Zitat Akdoğan M, Calguneri M, Yavuz B et al (2006) Are familial mediterranean fever (FMF) patients at risk for atherosclerosis? Impaired endothelial function and increased intima media thickness. J Am Coll Cardiol 48:2351–2353PubMedCrossRef Akdoğan M, Calguneri M, Yavuz B et al (2006) Are familial mediterranean fever (FMF) patients at risk for atherosclerosis? Impaired endothelial function and increased intima media thickness. J Am Coll Cardiol 48:2351–2353PubMedCrossRef
10.
Zurück zum Zitat Peru H, Altun B, Doğan M et al (2008) The evaluation of carotid intima-media thickness in children with familial mediterranean fever. Clin Rheumatol 27:689–694PubMedCrossRef Peru H, Altun B, Doğan M et al (2008) The evaluation of carotid intima-media thickness in children with familial mediterranean fever. Clin Rheumatol 27:689–694PubMedCrossRef
11.
Zurück zum Zitat Bilginer Y, Ozaltin F, Basaran C et al (2008) Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int 28:1211–1216PubMedCrossRef Bilginer Y, Ozaltin F, Basaran C et al (2008) Evaluation of intima media thickness of the common and internal carotid arteries with inflammatory markers in familial mediterranean fever as possible predictors for atherosclerosis. Rheumatol Int 28:1211–1216PubMedCrossRef
12.
13.
Zurück zum Zitat Sarı I, Karaoglu O, Can G et al (2007) Early ultrasonographic markers of atherosclerosis in patients with familial mediterranean fever. Clin Rheumatol 26:1467–1473PubMedCrossRef Sarı I, Karaoglu O, Can G et al (2007) Early ultrasonographic markers of atherosclerosis in patients with familial mediterranean fever. Clin Rheumatol 26:1467–1473PubMedCrossRef
14.
Zurück zum Zitat Martin JF, Trowbridge EA, Salmon G et al (1983) The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32:443–460PubMedCrossRef Martin JF, Trowbridge EA, Salmon G et al (1983) The biological significance of platelet volume: its relationship to bleeding time, thromboxane B2 production and megakaryocyte nuclear DNA concentration. Thromb Res 32:443–460PubMedCrossRef
15.
Zurück zum Zitat Turkish FMF Study Group (2005) Familial mediterranean fever in Turkey; results of a nationwide multicenter study. Medicine 84:1–11CrossRef Turkish FMF Study Group (2005) Familial mediterranean fever in Turkey; results of a nationwide multicenter study. Medicine 84:1–11CrossRef
16.
Zurück zum Zitat Coban E, Adanir H (2008) Platelet activation in patients with familial mediterranean fever. Platelets 19:405–408PubMedCrossRef Coban E, Adanir H (2008) Platelet activation in patients with familial mediterranean fever. Platelets 19:405–408PubMedCrossRef
17.
Zurück zum Zitat Makay B, Turkyilmaz Z, Unsal E (2009) Mean platelet volume in children with familial mediterranean fever. Clin Rheumatol 28:975–978PubMedCrossRef Makay B, Turkyilmaz Z, Unsal E (2009) Mean platelet volume in children with familial mediterranean fever. Clin Rheumatol 28:975–978PubMedCrossRef
18.
Zurück zum Zitat Thompson CB, Eaton KA, Princiotta SM et al (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50:509–519PubMedCrossRef Thompson CB, Eaton KA, Princiotta SM et al (1982) Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. Br J Haematol 50:509–519PubMedCrossRef
19.
Zurück zum Zitat Kilciler G, Genc H, Tapan S et al (2010) Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. Upsala J Med Sci 115:253–259PubMedCrossRef Kilciler G, Genc H, Tapan S et al (2010) Mean platelet volume and its relationship with carotid atherosclerosis in subjects with non-alcoholic fatty liver disease. Upsala J Med Sci 115:253–259PubMedCrossRef
20.
Zurück zum Zitat Seyahi E, Ugurlu S, Cumali R, et al (2005) Subclinical atherosclerosis in familial mediterranean fever. In: Proceedings of the 4th international congress on systemic auto-inflammatory diseases. FMF and Beyond, NIAMS, Bethesda, pp 6–10 Seyahi E, Ugurlu S, Cumali R, et al (2005) Subclinical atherosclerosis in familial mediterranean fever. In: Proceedings of the 4th international congress on systemic auto-inflammatory diseases. FMF and Beyond, NIAMS, Bethesda, pp 6–10
21.
Zurück zum Zitat Clarke D, Johnson PW, Banks RE et al (1996) Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine 8:717–723PubMedCrossRef Clarke D, Johnson PW, Banks RE et al (1996) Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine 8:717–723PubMedCrossRef
22.
Zurück zum Zitat Baykal Y, Saglam K, Yilmaz MI et al (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial mediterranean fever patients. Clin Rheumatol 22:99–101PubMedCrossRef Baykal Y, Saglam K, Yilmaz MI et al (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial mediterranean fever patients. Clin Rheumatol 22:99–101PubMedCrossRef
23.
Zurück zum Zitat Kaser A, Brandacher G, Steurer W et al (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98:2720–2725PubMedCrossRef Kaser A, Brandacher G, Steurer W et al (2001) Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98:2720–2725PubMedCrossRef
24.
Zurück zum Zitat Van Gameren MM, Willemse PH, Mulder NH et al (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I–II study. Blood 84:1434–1441PubMed Van Gameren MM, Willemse PH, Mulder NH et al (1994) Effects of recombinant human interleukin-6 in cancer patients: a phase I–II study. Blood 84:1434–1441PubMed
Metadaten
Titel
Evaluation of the mean platelet volume in children with familial Mediterranean fever
verfasst von
Seçil Arıca
Cahit Özer
Vefik Arıca
Ali Karakuş
Tanju Çelik
Ramazan Güneşaçar
Publikationsdatum
01.11.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 11/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2251-x

Weitere Artikel der Ausgabe 11/2012

Rheumatology International 11/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.